−3.68 CHF
−98.18 M CHF
6.03 M CHF
8.26 M
About RELIEF THERAPEUTICS N
Sector
Headquarters
Geneva
Founded
2013
Website
ISIN
CH1251125998
FIGI
BBG00JYV5QZ1
RELIEF THERAPEUTICS Holding SA is a commercial-stage biopharmaceutical company, which engages in the research, development, and commercialization of treatment for rare debilitating conditions. The firm offers Physiomimic and TEHCLO, drug delivery platform technologies and a targeted clinical development pipeline consisting of risk-mitigated assets to address rare metabolic disorders, rare skin diseases, and rare respiratory diseases. It operates through the following geographical segments: Switzerland, Europe, North America, and Rest of the World. The company was founded in 2013 and is headquartered in Geneva, Switzerland.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0QKQ is 4.92 CHF — it has decreased by −1.99% in the past 24 hours. Watch RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) stocks are traded under the ticker 0QKQ.
0QKQ stock has fallen by −27.22% compared to the previous week, the month change is a −13.07% fall, over the last year RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) has showed a 158.95% increase.
0QKQ reached its all-time high on Aug 10, 2020 with the price of 275.56 CHF, and its all-time low was 0.40 CHF and was reached on Dec 23, 2019. View more price dynamics on 0QKQ chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0QKQ stock is 9.76% volatile and has beta coefficient of −2.01. Track RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) stock price on the chart and check out the list of the most volatile stocks — is RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) there?
Today RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) has the market capitalization of 62.70 M, it has decreased by −13.11% over the last week.
Yes, you can track RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) financials in yearly and quarterly reports right on TradingView.
0QKQ net income for the last half-year is −4.56 M CHF, while the previous report showed −41.68 M CHF of net income which accounts for 89.07% change. Track more RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) financial stats to get the full picture.
No, 0QKQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) EBITDA is −9.26 M CHF, and current EBITDA margin is −274.92%. See more stats in RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) financial statements.
Like other stocks, 0QKQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) stock shows the neutral signal. See more of RELIEF THERAPEUTICS HOLDING AG CHF4.00 (REGD) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.